Moderately to severely immunocompromised patients are now recommended to receive a third dose of the Pfizer or Moderna vaccine at least 28 days after the completion of their initial mRNA COVID-19 vaccine series. Please note, this is not a booster and only applies to immunocompromised patients.

​

Melrose Pharmacy only provides the Moderna COVID-19 vaccine. To receive a third dose from Melrose Pharmacy, you must:

• Be 18 years or older

• Be moderately to severely immunocompromised:

  • Receiving active cancer treatment for tumors or cancers of the blood

  • Received an organ transplant and am taking medicine to suppress the immune system

  • Received a stem cell transplant within the last 2 years or am taking medicine to suppress the immune system

  • Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)

  • Have advanced or untreated HIV infection

  • Have active treatment with high-dose corticosteroids or other drugs that may suppress my immune response

A booster dose is recommended at least 6 months after the date of the second dose of Pfizer or Moderna, or 2 months if you received Janssen first dose. You may receive Moderna booster dose no matter what brand you received for the first and second dose.

​

Eligible recipients of the booster dose include:

• Adults aged 65 or older

• Adults 50 to 64 with an underlying medical condition

• Adults 18 to 49 with an underlying medical condition, and feel the need for an additional dose based off individual benefits and risks

• Adults 18 to 64 at an increased risk of COVID-19 exposure and transmission because of occupational or instituional settings

• Adults 18 to 64 who received Janssen (J&J) for their first dose